Vaccine order boosts Bavarian Nordic after cancer drug flop
COPENHAGEN (Reuters) - Biotech group Bavarian Nordic said it expected to win more contracts in the United States for its smallpox vaccine after securing an order from the U.S. government stockpile. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Teen died after HPV jab as experts brand vaccine 'useless'
EXCLUSIVE: Jasmin Soriat, 19, from Vienna, suffered respiratory failure weeks after having a second HPV jab. Doctors sensationally claim the HPV virus does not cause cancer in a documentary. (Source: the Mail online | Health)
Source: the Mail online | Health - September 27, 2017 Category: Consumer Health News Source Type: news

Vaccines are covertly injecting everyone with disease-causing viruses, warns scientist author of "Plague"
(Natural News) Judy A.  Mikovits, Ph.D., is  a research scientist, as well as the co-author of the recently released ground-breaking book, Plague. Mikovits has spent a lifetime studying autoimmune and neuroimmune diseases, cancer, and other conditions caused by chronic inflammation. Specifically, she’s been studying retroviruses and how they contribute to the onset of these life-altering conditions.... (Source: NaturalNews.com)
Source: NaturalNews.com - September 26, 2017 Category: Consumer Health News Source Type: news

Cambridge's Genocea cuts staff and shelves lead drug in major shakeup
Cambridge-based Genocea Biosciences said Monday that it is laying off around 40 of its 100 employees and seeking to unload a genital herpes vaccine program as it shifts its focus to developing cancer treatments. Genocea (Nasdaq: GNCA) said it was ceasing all spending and development activities related to GEN-003, which the company previously touted as a potential blockbuster. Genocea said it was “exploring strategic alternatives” for the vaccine, typically shorthand for a sale or other transaction. T he… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 25, 2017 Category: American Health Authors: Max Stendahl Source Type: news

Cambridge's Genocea cuts staff and shelves lead drug in major shakeup
Cambridge-based Genocea Biosciences said Monday that it is laying off around 40 of its 100 employees and seeking to unload a genital herpes vaccine program as it shifts its focus to developing cancer treatments. Genocea (Nasdaq: GNCA) said it was ceasing all spending and development activities related to GEN-003, which the company previously touted as a potential blockbuster. Genocea said it was “exploring strategic alternatives” for the vaccine, typically shorthand for a sale or other transaction. T he… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
PROVIDENCE, R.I., Sept. 25, 2017 -- (Healthcare Sales & Marketing Network) -- EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused o... Biopharmaceuticals, Personalized Medicine, Oncology EpiVax, EpiVax Oncology, epitopes, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2017 Category: Pharmaceuticals Source Type: news

Cancer vaccines need to target T cells that can persist in the long fight against cancer
(Medical College of Georgia at Augusta University) Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer, show that while one starts off with a bang, the other endures as the more powerful tumor fighter. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2017 Category: International Medicine & Public Health Source Type: news

OncoQR ’s S-TIR vaccine technology helps induce killing of cancer cells
Austrian start-up OncoQR ML has confirmed that a single therapeutic vaccine based on its Specific Total Immune Remodeler (S-TIR) platform is capable of simultaneously inducing and activating the killing of tumour target expressing cells. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Cancer industry frustrated that children treated with chemotherapy aren't getting enough HPV vaccines
(Natural News) The Advisory Committee on Immunization Practices, the panel that makes vaccine policy recommendations for the mainstream medical community, has for several years now been pushing for the routine HPV vaccination of young boys and girls. Their recommendation has also been endorsed by many other health organizations. Along with the rest of the adolescent... (Source: NaturalNews.com)
Source: NaturalNews.com - September 21, 2017 Category: Consumer Health News Source Type: news

Flu vaccine used in elderly may benefit middle-aged adults with chronic conditions
(University of Pittsburgh Schools of the Health Sciences) Expanding the high-dose influenza vaccine recommendation to include middle-aged adults with chronic health conditions may make economic sense and save lives. The findings may justify for clinical trials of the high-dose and new recombinant trivalent influenza vaccines in 50- to 64-year-old adults with chronic illnesses, such as heart or lung disease, diabetes, or cancer, to determine if they do provide considerably better protection than the currently recommended standard dose quadrivalent vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 21, 2017 Category: International Medicine & Public Health Source Type: news

Read Barack Obama ’s Speech Bashing the GOP’s ’50th or 60th’ Attempt to Repeal Obamacare
In conclusion, each of us can make a difference, and I know I’m preaching to the choir here because otherwise you wouldn’t be a goalkeeper. But many of you are young and maybe have only seen forward momentum and may not have seen backward momentum yet. Many of you may confront hurdles and roadblocks and disappointments in the future. And when that happens, that’s the test. The test is not how you feel when things are going good or when you are at a cool conference in New York with Bill and Melinda Gates, and Will I Am. The test is when you’re in the field and you’re on the ground and you are d...
Source: TIME.com: Top Science and Health Stories - September 20, 2017 Category: Consumer Health News Authors: Aric Jenkins Tags: Uncategorized Barack Obama onetime Source Type: news

HPV vaccine does NOT cause fertility problems
Boston researchers say the anti-cancer HPV jab has a protective effect on fertility. Both HPV infection and the vaccine itself has been linked to reduced semen quality and lower pregnancy rates. (Source: the Mail online | Health)
Source: the Mail online | Health - September 20, 2017 Category: Consumer Health News Source Type: news

National Cancer Institute designates UCLA brain cancer program a site of research excellence
The brain cancer program at UCLA ’s Jonsson Comprehensive Cancer Center and the UCLA Brain Tumor Center has been designated a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute, making it one of only five brain cancer programs nationwide to receive this national recognition and substantial rese arch funding.The designation comes with an $11.4 million, five-year grant that recognizes UCLA ’s brain cancer program as one of the best in the country. The program supports research into the prevention, detection and treatment of one of the most lethal and deadly cancers, which often...
Source: UCLA Newsroom: Health Sciences - September 20, 2017 Category: Universities & Medical Training Source Type: news

HPV Vaccination Strategies for Cancer Prevention
September 29, 2017 12:30-1:30pm ET. (Source: PHPartners.org)
Source: PHPartners.org - September 19, 2017 Category: International Medicine & Public Health Source Type: news

Futile: Prostate Cancer Vaccine Phase 3 Trial Ends Futile: Prostate Cancer Vaccine Phase 3 Trial Ends
Prostvac is an immunotherapy designed to induce T-cell responses and thus kill prostate cancer cells. As a monotherapy, it is not effective.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Screening for cervical abnormalities in women offered HPV vaccination
(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 19, 2017 Category: Cancer & Oncology Source Type: news

Single-injection vaccine device still a long way off
Conclusion Injection of a microstructure device that can give time-delayed release of a vaccine or drug could have great potential in medicine. As the researchers noted, the structures are tiny and fully biodegradable, so they shouldn't cause a foreign-body reaction. But they also mentioned the size – the lightweight device could only hold a small amount of solution. However, the researchers suggested that varying the wall thickness to create larger cores could greatly increase the device's capacity. At this stage, the device has only been tested in a single experiment in mice. Further research in mice would be nee...
Source: NHS News Feed - September 18, 2017 Category: Consumer Health News Tags: Pregnancy/child Source Type: news

Selena Gomez ’ s kidney transplant: Young, minority women disproportionately affected by lupus
In the world of celebrities, there are diseases such as HIV/AIDS and breast cancer that are very “popular” and well understood, thanks to years of fundraising and awareness campaigns by stars. And there are those diseases that are less so. Lupus, an autoimmune disorder that can damage organs, is in the second category. When Selena Gomez shocked her 126 […]Related:To fight deadly hepatitis outbreak, San Diego begins power-washing streets with bleachWhat to know about a study of flu vaccine and miscarriageMelinda Gates decries ‘loss of U.S. leadership’ in global aid (Source:...
Source: Washington Post: To Your Health - September 14, 2017 Category: Consumer Health News Source Type: news

Retroviruses: Poorly Understood Agents of Change
Investigating the alarming rise of chronic inflammatory diseases (Natural News) Chronic inflammatory diseases have been skyrocketing in incidence in the past quarter century. The details explaining how retroviruses in today’s biological therapeutics including vaccines are contributing to autoimmune, neuroimmune disease and cancer are complex. Although I’ve spent my adult lifetime studying how retroviruses contribute to... (Source: NaturalNews.com)
Source: NaturalNews.com - September 9, 2017 Category: Consumer Health News Source Type: news

HPV Vaccine May Even Protect Women Who Never Got It
'Herd immunity' effect shows U.S. females now less likely to contract the cancer-causing virus (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - September 9, 2017 Category: Cancer & Oncology Source Type: news

HPV Vaccine May Even Protect Women Who Never Got It
' Herd immunity'effect shows U.S. females now less likely to contract the cancer - causing virus (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 8, 2017 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, News, Source Type: news

HPV Vaccine May Even Protect Women Who Never Got It
'Herd immunity' effect shows U.S. females now less likely to contract the cancer-causing virus Source: HealthDay Related MedlinePlus Pages: HPV, Immunization, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 8, 2017 Category: Consumer Health News Source Type: news

East Bay company snares $93M to zap cancers as they zig and zag
Its headquarters are in Emeryville, its new manufacturing space is in Pleasanton and Gritstone Oncology plans to give its cancer vaccine to patients next year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 7, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

East Bay company snares $93M to zap cancers as they zig and zag
Its headquarters are in Emeryville, its new manufacturing space is in Pleasanton and Gritstone Oncology plans to give its cancer vaccine to patients next year. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 7, 2017 Category: American Health Authors: Ron Leuty Source Type: news

Study shows vaccine confirmed to reduce and eradicate cervical cancer
The benefits of Gardasil are wildly debated across the United States by concerned parents, and the University of Alabama at Birmingham is paying attention. UAB's Comprehensive Cancer Center, along with a medical coalition of Alabama health groups, have made inroads into displaying Gardasil's effectiveness. According to a new study from the coalition, recent results confirm that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers. D r. Warner Huh, professor and director in the gynecologic… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 7, 2017 Category: Health Management Authors: Tyler Patchen Source Type: news

Personalized Cancer Vaccine Company Raises $93 Million
Venture funds seeded by drug giant Eli Lilly and search behemoth Alphabet are giving $92.7 million to a startup that aims to use machine learning to create personalized treatments for lung and stomach cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 7, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:LLY NASDAQ:GOOG Source Type: news

New vaccine protects against nine types of HPV
Researchers at the H. Lee Moffitt Cancer Center& Research Institute found that an improved vaccine is able to protect against nine types of HPV. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 6, 2017 Category: Consumer Health News Source Type: news

NAS, NAM Members Receive Lasker Awards
The Albert and Mary Lasker Foundation announced today that NAS member Michael N. Hall, professor, Biozentrum, University of Basel, Switzerland, is the recipient of the 2017 Albert Lasker Basic Medical Research Award for"discoveries concerning the nutrient-activated TOR proteins and their central role in the metabolic control of cell growth." Dual NAS/NAM member Douglas Lowy, acting director of the National Cancer Institute, has been awarded the 2017 Lasker~DeBakey Clinical Medical Research Award, along with John T. Schiller of the NCI, for"technological advances that enabled development of HPV vaccines for p...
Source: News from the National Academies - September 6, 2017 Category: Science Source Type: news

3 Scientists and Planned Parenthood Win Lasker Prizes for Medical Research
(NEW YORK) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards. The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium. The foundation’s clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical can...
Source: TIME.com: Top Science and Health Stories - September 6, 2017 Category: Consumer Health News Authors: Malcolm Ritter / AP Tags: Uncategorized awards medical research onetime Planned Parenthood Science Source Type: news

HPV researchers, Planned Parenthood win prestigious Lasker medical awards
The Lasker Awards, among the most prestigious in medicine, will go to two National Cancer Institute researchers whose work led to the development of vaccines that prevent cervical cancer, and to Planned Parenthood for providing “essential health services and reproductive care” to millions of women, the Albert and Mary Lasker Foundation said Wednesday. In announcing the awards, […]Related:The health dangers from Hurricane Harvey’s floods and Houston’s chemical plantsFDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemiaThe hurricane ...
Source: Washington Post: To Your Health - September 6, 2017 Category: Consumer Health News Source Type: news

New study finds improved vaccine that protects against nine types of HPV
(H. Lee Moffitt Cancer Center& Research Institute) Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 6, 2017 Category: Cancer & Oncology Source Type: news

New technique gives a clearer image of immunotherapy results in advanced brain cancer
FINDINGSResearchers led by Robert Prins, a member of the UCLA Jonsson Comprehensive Cancer Center, have developed a new approach for brain imaging that can better distinguish immune responses from tumor growth in both preclinical studies and in people with glioblastoma.BACKGROUNDDespite clinical advances in immunotherapy for cancer, non-invasive monitoring of tumor growth (especially in people with brain tumors) has been a significant problem. When clinicians use traditional medical imaging processes, the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.METHODPrins...
Source: UCLA Newsroom: Health Sciences - September 5, 2017 Category: Universities & Medical Training Source Type: news

Vaccines are made with the same chemical found to increase breast cancer risk among women who have mutations of the BRCA genes
(Natural News) Where breast or ovarian cancer seems to “run” in a family, both male and female family members are encouraged to undergo testing to see whether they may have mutations in their BRCA1 or BRCA2 genes. These genes are responsible for suppressing tumor proteins, and when they have mutated (or altered), certain types of... (Source: NaturalNews.com)
Source: NaturalNews.com - September 5, 2017 Category: Consumer Health News Source Type: news

New study finds improved vaccine that protects against nine types of HPV
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: World Pharma News)
Source: World Pharma News - September 5, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Vaccine to prevent most cervical cancers shows long-term effectiveness
This study of 14,215 women in 18 countries extends and solidifies the initial phase 3 efficacy and safety trial of the nine-valent human papilloma virus vaccine, Gardasil 9, that was published in February 2015 in The New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 5, 2017 Category: Cancer & Oncology Source Type: news

Few young cancer survivors are up to date with HPV vaccines
(Reuters Health) - Childhood cancer survivors in the U.S. are much less likely to have had human papillomavirus (HPV) vaccinations compared to their peers, despite being at increased risk from the virus, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - August 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA clears first gene-altering therapy — ‘ a living drug ’ — for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' genetically altered immune cells to fight the disease. It is the first gene therapy to be cleared in the United States — a “historic” action, the agency said -- and one with major ramifications for patients with […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA clears first gene-altering therapy — ‘ a living drug ’ — for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' genetically altered immune cells to fight the disease. It is the first gene therapy to be cleared in the United States — a “historic” action, the agency said — and one with major ramifications for patients with […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

FDA approves first-of-its-kind ‘ living drug ’ for childhood leukemia
The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' own genetically altered immune cells to fight the disease. It is the first gene therapy to be allowed in the United States — a “historic” approval, the agency said. The decision clears the Novartis drug, called Kymriah, […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’ (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 30, 2017 Category: Consumer Health News Source Type: news

Health Tip: Getting the HPV Vaccine
-- Human papillomavirus (HPV) is a sexually transmitted disease that has been linked to cancer of the cervix and a host of other cancers. The HPV vaccine is designed to prevent infection by the HPV-16 and HPV-18 strains of the virus, which are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2017 Category: General Medicine Source Type: news

Health Tip: Getting the HPV Vaccine
Who should get it, and at what age (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - August 30, 2017 Category: Cancer & Oncology Source Type: news

Religious young women less educated about HPV vaccine
(Reuters Health) - Religious young women are less knowledgeable about a vaccine that guards against several different types of cancer, suggests a new study from Utah. (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

HPV vaccination rates especially low among childhood cancer survivors
(American Society of Clinical Oncology) The rate of human papilloma virus (HPV) vaccination in the United States is increasing, but remains lower than ideal. A new study suggests that survivors of childhood cancer receive the HPV vaccine at an even lower rate than their peers without cancer -- 24 percent versus 40 percent. Nearly three-quarters of study participants reported that their healthcare provider did not proactively recommend vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 29, 2017 Category: Cancer & Oncology Source Type: news

FDA intervenes after stem cell center offers unproven treatment to cancer patients
The FDA is cracking down on stem cell clinics that administer unproven and potentially dangerous treatments to patients, citing a California-based clinic that the regulatory watchdog said was treating cancer patients with the smallpox vaccine. Last week, the U.S. Marshals Service seized five vials of a vaccine that is reserved only for people at high risk for smallpox. The FDA said that StemImmune, a stem cell clinic in San Diego, had mixed the vaccine with fat-derived stem cells and injected it intravenously into patients’ tumors at the California Stem Cell Treatment Centers. Get the full story at our sister si...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Regulatory/Compliance Stem Cells Source Type: news

The hurricane came, and these newborns refused to wait out the storm
HOUSTON — Large swaths of South Texas ground to a halt as Harvey dumped dozens of inches of rain on everything in its path. Some schools are closed until next month. Thousands of flights were canceled. Travel was stalled for anyone without a functioning boat. But some things could not wait. Particularly, the arrival of […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?Fewer antibiotic prescriptions are being filled, a new analysis finds (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 28, 2017 Category: Consumer Health News Source Type: news

FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patients
The Food and Drug Administration on Monday announced a crackdown on stem-cell clinics offering unproven and potentially dangerous treatments, including an operation in California that the agency said was using the smallpox vaccine on seriously ill cancer patients. U.S. marshals on Friday raided San Diego-based StemImmune and seized the vaccine, which the FDA said had […]Related:Does talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’Tibetan Buddhism-based ‘compassion’ training for doctors targets burnout (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 28, 2017 Category: Consumer Health News Source Type: news

Boosting immune cell memory to improve vaccines and cancer immunotherapy
(University of California - San Diego) In mouse experiments, researchers at University of California San Diego School of Medicine have discovered that drugs that activate the cells' proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells. This approach could be used to improve how well vaccines and immunotherapies work and how long they last. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 28, 2017 Category: Cancer & Oncology Source Type: news

HPV Vaccine Uptake Lags in Cancer Survivors (CME/CE)
(MedPage Today) -- Lack of provider recommendation a key factor (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 25, 2017 Category: American Health Source Type: news

HPV vaccine: What is the virus linked to anal cancer and how is it spread?
HPV has been linked to anal cancer, cervical cancer and mouth cancer, but few people know what the virus is or how people can be infected by it. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2017 Category: Consumer Health News Source Type: news